Risks of requiring a dedicated molecular specimen for HIV diagnosis and a potential strategy for mitigation.

Published in: PloS one (2020)

We propose utilizing quantitative fourth-generation assay results (S/CO) ratios as a predictor of infection true positivity in situations where the screening assay is reactive but the supplemental test is negative and confirmatory molecular results are not immediately available.

Keyphrases

high throughput
antiretroviral therapy
human health
hiv infected
climate change
hiv positive
human immunodeficiency virus
hepatitis c virus
hiv aids
hiv testing
mass spectrometry